http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103417560-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be61f9be3a3b8502e9392d4e595ff342 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 |
| filingDate | 2012-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103417560-A |
| titleOfInvention | Application of harpagoside to resist primary hypertension |
| abstract | The invention belongs to the technical field of biological medicines, and relates to a new application of harpagoside to resist primary hypertension. The application is characterized in that the invention describes the application of harpagoside to preparation of medicaments for controlling primary hypertension, and also describes compositions for controlling hypertension, which contains the above compound. |
| priorityDate | 2012-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 190.